Syndax Pharmaceuticals, Inc. · NASDAQ:SNDX
Point72 Asset Management, L.P.'s stake in Syndax Pharmaceuticals, Inc. fell to 2.30% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Point72 Asset Management, L.P.'s stake in Syndax Pharmaceuticals, Inc. fell to 2.30%, 1,985,547 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 2.30%
- Shares
- 1,985,547
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 2.30% | 1,985,547 |
| Point72 Capital Advisors, Inc. | 2.30% | 1,985,547 |
| Steven A. Cohen | 2.30% | 1,985,547 |
Source
Related
- Syndax Pharmaceuticals, Inc.
- Point72 Asset Management, L.P.
- Syndax Pharmaceuticals, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Aug 18, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · Point72 Asset Management, L.P. · Jan 22, 2025
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Metzger Michael A · Jul 9, 2026
- Form 4 · Botwood Nicholas A.J. · Jun 12, 2026
- Form 4 · Goldan Keith A. · Jun 2, 2026
- Form 4 · Metzger Michael A · Jun 2, 2026